You just read:

Spero Therapeutics Announces $1.65 Million Award from Department of Defense to Develop Novel Combination Therapy for Multidrug-Resistant, Gram-Negative Pathogens

News provided by

Spero Therapeutics

18 Oct, 2016, 09:00 ET